rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Frank Litvack

Director

Company insider

Files Form 4 as: Director and 10% owner, Capricor Therapeutics; CEO and Chairman, Conor Medsystems.

Every Form 4 they filed

In numbers

Trades disclosed
71
Buys
0
Sells
2
Bought
$0
Sold
$2.9M
Companies
2
Companies where not an officer
1
First trade
27 Feb 2006
Last trade
13 May 2026
Last filed
14 May 2026

Companies traded

Where they are an officer
Conor MedsystemsDirector, Officer · last 1 Feb 20070 buys · 2 sells
Everywhere else they filed: board seats, 10% stakes, other companies
CAPR Capricor TherapeuticsDirector, 10% owner · Biotechnology · last 13 May 20260 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
13 May 2026filed 14 May 2026CAPR Capricor TherapeuticsBiotechnologySEC FORM 4 Code M$5,4723,937 at $1.39filing
13 May 2026filed 14 May 2026CAPR Capricor Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code M—3,937 at $0.00filing
13 May 2026filed 14 May 2026CAPR Capricor Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code M—3,937 at $0.00filing
13 May 2026filed 14 May 2026CAPR Capricor TherapeuticsBiotechnologySEC FORM 4 Code M$5,4723,937 at $1.39filing
5 Jan 2026filed 7 Jan 2026CAPR Capricor Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
5 Jan 2026filed 7 Jan 2026CAPR Capricor Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
3 Mar 2025filed 4 Mar 2025CAPR Capricor Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code M—25,000 at $0.00filing
3 Mar 2025filed 4 Mar 2025CAPR Capricor TherapeuticsBiotechnologySEC FORM 4 Code M$35K25,000 at $1.39filing
3 Mar 2025filed 4 Mar 2025CAPR Capricor TherapeuticsBiotechnologySEC FORM 4 Code F$35K2,543 at $13.67filing
2 Jan 2025filed 6 Jan 2025CAPR Capricor Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
3 Dec 2024filed 4 Dec 2024CAPR Capricor Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code M—20,391 at $0.00filing
3 Dec 2024filed 4 Dec 2024CAPR Capricor TherapeuticsBiotechnologySEC FORM 4 Code M$22K20,391 at $1.10filing
2 Dec 2024filed 4 Dec 2024CAPR Capricor Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code G—20,391 at $0.00filing
2 Dec 2024filed 4 Dec 2024CAPR Capricor Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code G—20,391 at $0.00filing
2 Jan 2024filed 4 Jan 2024CAPR Capricor Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—200,000 at $0.00filing
14 Aug 2023filed 16 Aug 2023CAPR Capricor Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code M—20,748 at $0.00filing
14 Aug 2023filed 16 Aug 2023CAPR Capricor TherapeuticsBiotechnologySEC FORM 4 Code M$29K20,748 at $1.39filing
14 Aug 2023filed 16 Aug 2023CAPR Capricor TherapeuticsBiotechnologySEC FORM 4 Code F$29K4,364 at $6.61filing
21 Feb 2023filed 23 Feb 2023CAPR Capricor Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code M—14,027 at $0.00filing
21 Feb 2023filed 23 Feb 2023CAPR Capricor TherapeuticsBiotechnologySEC FORM 4 Code M$19K14,027 at $1.39filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed2

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.